BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16859699)

  • 21. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role of fatty acid oxidation in cardiac hypertrophy.
    Bressler R; Goldman S
    Cardioscience; 1993 Sep; 4(3):133-42. PubMed ID: 8400020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of myocardial enzymes related to glycolysis and fatty acid metabolism in chronic myocardial ischemia: experiment with pigs].
    Gong J; Wang HY; Pu JL; Zheng YL; Shen R; Yang MF; He ZX
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2209-13. PubMed ID: 19080674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium.
    Itoh S; Ding B; Shishido T; Lerner-Marmarosh N; Wang N; Maekawa N; Berk BC; Takeishi Y; Yan C; Blaxall BC; Abe J
    Circulation; 2006 Apr; 113(14):1787-98. PubMed ID: 16585392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.
    Cabrero A; Jové M; Planavila A; Merlos M; Laguna JC; Vázquez-Carrera M
    Mol Pharmacol; 2003 Sep; 64(3):764-72. PubMed ID: 12920214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression.
    Vega VA; Anzulovich AC; Varas SM; Bonomi MR; Giménez MS; Oliveros LB
    Nutrition; 2009; 25(7-8):828-38. PubMed ID: 19342198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
    Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression.
    van den Brink OW; Delbridge LM; Pedrazzini T; Rosenfeldt FL; Pepe S
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):153-9. PubMed ID: 18205093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart.
    Karbowska J; Kochan Z; Smoleński RT
    Cell Mol Biol Lett; 2003; 8(1):49-53. PubMed ID: 12655356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis.
    Tang Z; McGowan BS; Huber SA; McTiernan CF; Addya S; Surrey S; Kubota T; Fortina P; Higuchi Y; Diamond MA; Wyre DS; Feldman AM
    J Mol Cell Cardiol; 2004 Apr; 36(4):515-30. PubMed ID: 15081311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice.
    Ueno M; Suzuki J; Zenimaru Y; Takahashi S; Koizumi T; Noriki S; Yamaguchi O; Otsu K; Shen WJ; Kraemer FB; Miyamori I
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1109-18. PubMed ID: 18413675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
    Purushothaman S; Sathik MM; Nair RR
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Luptak I; Balschi JA; Xing Y; Leone TC; Kelly DP; Tian R
    Circulation; 2005 Oct; 112(15):2339-46. PubMed ID: 16203912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
    Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.